Eastgate Biotech Corp. (OTCMKTS:ETBI)’s stock price passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.01 and traded as low as $0.00. Eastgate Biotech shares last traded at $0.00, with a volume of 30,000 shares trading hands. The firm has a fifty day moving average of $0.01 and a 200-day moving average of $0.01. Eastgate Biotech Corp. is a development stage company that develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. [7d279e05]